Krystal Biotech, Inc. (KRYS)

262.24 +0.44 (+0.17%) USD  |  NASDAQ  |  Feb 23, 10:59
More

Krystal Biotech Cash from Other Financing Activities (Quarterly)

Cash from Other Financing Activities (Quarterly) Chart

View Cash from Other Financing Activities (Quarterly) for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Other Financing Activities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash from Other Financing Activities (Quarterly) Range, Past 5 Years

View Cash from Other Financing Activities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Other Financing Activities (Quarterly) Benchmarks

View Cash from Other Financing Activities (Quarterly) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
DexCom, Inc. Upgrade
Alkermes Plc Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade